PORTLAND, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announces that it will be formally launching its corporate citizenship initiative coined, Paragon Gives.
On Sunday October 19, 2014, Paragon BioTeck, will kick off its newly branded corporate social responsibility initiative at the annual American Academy of Ophthalmology conference in Chicago, Ill. Paragon will be donating a portion of proceeds generated from the sales of its recently FDA cleared medical device, Comfortear® Lacrisolve™ Absorbable Punctum Plug.
“I am fortunate to be surrounded daily by a team of professionals that has a strong sense of community and social responsibility. For them, it’s not just a way of thinking, but rather a way of living. I believe this level of responsible interdependency fosters the personal and professional growth that we as a company can attribute to our continued good fortune and success. We are pleased to be able to use Paragon Gives as a vehicle to continue to build on these efforts,” says Patrick H. Witham, President & CEO of Paragon BioTeck, Inc.
About Comfortear® Lacrisolve™ Absorbable Punctum Plug
Comprised of the synthetic absorbable polymer, polydioxanone, the Comfortear® Lacrisolve™ Absorbable Punctum Plugs are medium-term implants designed to be inserted into the canaliculus in order to block tear drainage through the lacrimal drainage system. The Comfortear® Lacrisolve™ Absorbable Punctum Plugs are available in two diameters: 0.4mm and 0.5mm. The implants are supplied sterile with two implants per package. Absorption time for the Comfortear® Lacrisolve™ Absorbable Punctum Plugs is approximately 6 months (=<6).
About Paragon Gives
Paragon Gives supports a number of charities and organizations including those in the biotechnology and health care arena. In addition, Paragon works with those that are near to the hearts of their customers, vendors and investors. These organizations include Holt International, Pearl Buck Center and Susan G. Komen.
About Paragon BioTeck, Inc.
Paragon BioTeck, Inc., is a privately held ophthalmic-focused biopharmaceutical and medical device company pursuing the development and commercialization of products addressing unmet medical needs in the fight to protect and preserve eyesight.
For more information on the company and its work, please visit paragonbioteck.com or call 888-424-1192; or email info@paragonbioteck.com.
